Geron Corporation (GERN): Price and Financial Metrics
GERN Price/Volume Stats
| Current price | $2.89 | 52-week high | $5.34 |
| Prev. close | $2.92 | 52-week low | $1.64 |
| Day low | $2.85 | Volume | 8,638,100 |
| Day high | $2.99 | Avg. volume | 12,391,019 |
| 50-day MA | $3.73 | Dividend yield | N/A |
| 200-day MA | $4.11 | Market Cap | 1.75B |
GERN Stock Price Chart Interactive Chart >
Geron Corporation (GERN) Company Bio
Geron Corporation focuses on the development of telomerase inhibitor, imetelstat, for treating hematologic myeloid malignancies. The company was founded in 1990 and is based in Menlo Park, California.
GERN Price Returns
| 1-mo | -17.19% |
| 3-mo | -28.99% |
| 6-mo | -32.63% |
| 1-year | 41.67% |
| 3-year | 175.24% |
| 5-year | 106.43% |
| YTD | -18.36% |
| 2024 | 67.77% |
| 2023 | -12.81% |
| 2022 | 98.36% |
| 2021 | -23.27% |
| 2020 | 16.91% |
Continue Researching GERN
Want to do more research on Geron Corp's stock and its price? Try the links below:Geron Corp (GERN) Stock Price | Nasdaq
Geron Corp (GERN) Stock Quote, History and News - Yahoo Finance
Geron Corp (GERN) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...